Scholtz & Company’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-21,468
Closed -$3.14M 55
2025
Q3
$3.14M Sell
21,468
-1,818
-8% -$275K 1.38% 27
2025
Q2
$3.63M Sell
23,286
-647
-3% -$103K 1.59% 25
2025
Q1
$3.94M Buy
23,933
+452
+2% +$75.2K 1.95% 22
2024
Q4
$3.83M Buy
23,481
+363
+2% +$64.9K 1.83% 21
2024
Q3
$4.52M Sell
23,118
-749
-3% -$138K 2.13% 17
2024
Q2
$4.14M Sell
23,867
-905
-4% -$151K 1.76% 23
2024
Q1
$4.19M Buy
24,772
+3,570
+17% +$669K 1.85% 21
2023
Q4
$4.18M Sell
21,202
-531
-2% -$94K 2.07% 17
2023
Q3
$3.78M Sell
21,733
-222
-1% -$40.3K 2.49% 14
2023
Q2
$3.78M Buy
21,955
+11,598
+112% +$2.01M 2.37% 17
2023
Q1
$1.72M Buy
10,357
+137
+1% +$22.5K 1.23% 24
2022
Q4
$1.5M Sell
10,220
-7,435
-42% -$1.1M 1.06% 22
2022
Q3
$2.62M Buy
+17,655
New +$2.95M 1.87% 18

Other funds holding ZTS

Scholtz & Company's ZTS Position: Q4 2025 in Review

Scholtz & Company sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 21,468 shares — an estimated $3.14M sold.

Scholtz & Company first reported a position in ZTS in Q3 2022 and held it in 13 quarters. The position peaked at $4.52M in Q3 2024. 1,679 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

  • Scholtz & Company reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
  • Scholtz & Company sold 21,468 Zoetis shares in Q4 2025, an estimated $3.14M.
  • Scholtz & Company first reported a position in Zoetis in Q3 2022 and held it in 13 quarters.
  • Scholtz & Company's Zoetis position peaked at $4.52M in Q3 2024.
  • 1,679 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Scholtz & Company's 13F filing for Q4 2025, filed 11 Feb 2026.